Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genistein for Childhood Obesity
NCT07033767Phase 2Not yet recruiting
- Sponsor
- Western University
- Start
- Aug 2025
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
01
Overview
Phase 2, open-label, single-arm trial of genistein in obesity, sponsored by Western University. Primary endpoint: Change in Body Mass Index z-score at 6 months. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
genistein
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07033767.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07033767.